LOXL2 抗体
KO Validated LOXL2 适用: 人 WB, ELISA, IHC, ICC, IHC (p), IF 宿主: 兔 Polyclonal unconjugated
LOXL2 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
LOXL2 适用: 人 WB, ELISA, IHC, IF, FACS 宿主: 兔 Monoclonal 2E5 unconjugated Recombinant Antibody
LOXL2 抗体 by Grade
Find LOXL2 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
LOXL2 抗体 by 抗体来源
Find LOXL2 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
LOXL2 抗体 by 克隆形成能力
Find available monoclonal or polyclonal LOXL2 抗体. Click on a link to go to the corresponding products.
LOXL2 抗体 by 克隆
Find LOXL2 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
LOXL2 抗体 by 标记
Find LOXL2 抗体 with a specific conjugate such as Biotin, FITC, HRP. The conjugates listed below are among those available. Click on a link to go to the corresponding products.
Popular LOXL2 抗体
- (5)
- (8)
- (7)
- (5)
- (3)
- (3)
- (2)
- (2)
- (2)
- (1)
- (1)
- (2)
- (3)
- (3)
- (1)
- (1)
- (1)
- (2)
Latest Publications for our LOXL2 抗体
: "LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells. ..." in: Oncogene, Vol. 39, Issue 1, pp. 79-121, (2020) (PubMed).: "LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype." in: Frontiers in oncology, Vol. 10, pp. 284, (2020) (PubMed).
: "Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB." in: Oncogenesis, Vol. 8, Issue 5, pp. 34, (2019) (PubMed).
: "Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis." in: Disease models & mechanisms, Vol. 10, Issue 11, pp. 1301-1312, (2018) (PubMed).
: "Association between lysyl oxidase and fibrotic focus in relation with inflammation in breast cancer." in: Oncology letters, Vol. 15, Issue 2, pp. 2431-2440, (2018) (PubMed).
: "Emerging role of LOXL2 in the promotion of pancreas cancer metastasis." in: Oncotarget, Vol. 7, Issue 27, pp. 42539-42552, (2018) (PubMed).
: "LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway." in: Scientific reports, Vol. 7, pp. 44988, (2018) (PubMed).
: "HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 60, (2018) (PubMed).
: "Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis." in: Scientific reports, Vol. 7, Issue 1, pp. 149, (2018) (PubMed).
: "Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis." in: Oncotarget, Vol. 8, Issue 46, pp. 80325-80335, (2017) (PubMed).
Aliases for LOXL2 抗体
lysyl oxidase like 2 (LOXL2) 抗体lysyl oxidase-like 2 (lox2) 抗体
lysyl oxidase-like 2 (Loxl2) 抗体
lysyl oxidase homolog 4 (LOC408544) 抗体
lysyl oxidase-like 2 (LOXL2) 抗体
lysyl oxidase like 2 L homeolog (loxl2.L) 抗体
lysyl oxidase like 2 (loxl2) 抗体
lysyl oxidase like 2 (Loxl2) 抗体
lysyl oxidase-like 2b (loxl2b) 抗体
1110004B06Rik 抗体
4930526G11Rik 抗体
9430067E15Rik 抗体
CG4402 抗体
Dmel\\CG4402 抗体
dmlox-2 抗体
Dmloxl-2 抗体
GB13360 抗体
im:7136137 抗体
LOR2 抗体
lor2 抗体
lox2-like 抗体
loxl-2 抗体
LOXL2 抗体
si:dkeyp-32b1.1 抗体
WS9-14 抗体
ws9-14 抗体
wu:fk12g04 抗体
zgc:158414 抗体